Skip to main content
FinSpry Logo
FinSpry
AKTX logo
AKTX
(NASDAQ)
Akari Therapeutics, Plc
$3.88-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Akari Therapeutics (AKTX) Stock Price & Financial Analysis

Akari Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.56 - $3.89
52-Week High$12.60
52-Week Low$0.22
Open$3.78
Volume25.50K
Average Volume (3M)25.50K
Market Cap146.00M
Shares Outstanding32.66M
Price to Book (P/B)5.15
EV/EBITDA-8.16
50-Day MA$8.27
200-Day MA$3.49
52-Week Change234.48%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Akari Therapeutics

What is the current stock price for AKTX?

As of the latest trading session, AKTX stock trades at $3.88. The 52-week range is $0.22–$12.60, with a day range of $3.56–$3.89.

What is the P/E ratio for AKTX?

The P/E ratio (Price-to-Earnings) for AKTX is shown in the Key Statistics section. This valuation metric helps compare Akari Therapeutics, Plc to industry peers.

Does AKTX pay dividends?

Akari Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AKTX?

Analyst ratings and recommendations for AKTX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of AKTX?

Akari Therapeutics's market capitalization is $126.7M, classifying it as a micro-cap company. Akari Therapeutics operates in the Healthcare sector within the Biotechnology industry.